Literature DB >> 29467124

Gastric and duodenal ischaemia after transarterial chemoembolisation for hepatocellular carcinoma: an unexpected but significant complication.

Sai Pavan Chintalapati1, Arpan Patel1, Hari Conjeevaram1.   

Abstract

Transarterial chemoembolisation (TACE) is commonly used for unresectable intermediate-stage hepatocellular carcinoma (HCC). TACE is usually well-tolerated. We report a case of a patient who presented with a gastrointestinal bleed from TACE. A 64-year-old man presented with chronic hepatitis C cirrhosis and multifocal bilobar HCC. He had previously undergone multiple TACE sessions, radiofrequency ablation and stereotactic body radiation therapy. In the evening of his TACE procedure, he developed abdominal pain and haematemesis. An oesophagogastroduodenoscopy (OGD) showed non-bleeding oesophageal varices and ulcerations in the stomach and duodenum, with pathology demonstrating mucosal necrosis. The patient recovered and was discharged on omeprazole. While TACE is considered safe with most patients only experiencing postembolisation syndrome, vascular complications have been reported. In our patient, OGD revealed ulcerations, with biopsies confirming ischaemic ulceration. The likely aetiology was seepage of the embolic particles into neighbouring arteries. Patients should be carefully selected for TACE and monitored post procedure. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Gi bleeding; hepatic cancer; hepatitis C; interventional radiology; ulcer

Mesh:

Substances:

Year:  2018        PMID: 29467124      PMCID: PMC5847979          DOI: 10.1136/bcr-2017-223339

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Hepatic arterial embolization complicated by acute cholecystitis.

Authors:  Rajesh P Shah; Karen T Brown
Journal:  Semin Intervent Radiol       Date:  2011-06       Impact factor: 1.513

2.  Management of hepatocellular carcinoma.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2005-11       Impact factor: 17.425

Review 3.  [Complications after TACE in HCC].

Authors:  S Schneeweiß; M Horger; D Ketelsen; S D Ioanoviciu
Journal:  Rofo       Date:  2015-01-28

4.  Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus statement.

Authors:  Roderich E Schwarz; Ghassan K Abou-Alfa; Jeffrey F Geschwind; Sunil Krishnan; Riad Salem; Alan P Venook
Journal:  HPB (Oxford)       Date:  2010-06       Impact factor: 3.647

5.  Anatomic and technical skill factor of gastroduodenal complication in post-transarterial embolization for hepatocellular carcinoma: a retrospective study of 280 cases.

Authors:  Ting-Kai Leung; Chi-Ming Lee; Hsin-Chi Chen
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

Review 6.  Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.

Authors:  Laura Marelli; Rosa Stigliano; Christos Triantos; Marco Senzolo; Evangelos Cholongitas; Neil Davies; Jonathan Tibballs; Tim Meyer; David W Patch; Andrew K Burroughs
Journal:  Cardiovasc Intervent Radiol       Date:  2007 Jan-Feb       Impact factor: 2.740

7.  A case of necrotizing pancreatitis subsequent to transcatheter arterial chemoembolization in a patient with hepatocellular carcinoma.

Authors:  Song-I Bae; Jong Eun Yeon; Jong Mee Lee; Ji Hoon Kim; Hyun Jung Lee; Sun Jae Lee; Sang Jun Suh; Eileen L Yoon; Hae Rim Kim; Kwan Soo Byun; Tae-Seok Seo
Journal:  Clin Mol Hepatol       Date:  2012-09-25

8.  Gastroduodenal lesions after transcatheter arterial chemo-embolization in patients with hepatocellular carcinoma.

Authors:  M Hirakawa; M Iida; K Aoyagi; T Matsui; K Akagi; M Fujishima
Journal:  Am J Gastroenterol       Date:  1988-08       Impact factor: 10.864

9.  Spinal cord ischemia secondary to transcatheter arterial chemoembolization for hepatocellular carcinoma.

Authors:  Aziz Bazine; Mohamed Fetohi; Maha Ait Berri; Ismail Essaadi; Kamal Elbakraoui; Mohamed Ichou; Hassan Errihani
Journal:  Case Rep Gastroenterol       Date:  2014-09-10
  9 in total
  3 in total

1.  The Prognostic Value of Inflammation Factors in Hepatocellular Carcinoma Patients with Hepatic Artery Interventional Treatments: A Retrospective Study.

Authors:  Linghong Guo; Honghong Ren; Lutong Pu; Xingyu Zhu; Yin Liu; Xuelei Ma
Journal:  Cancer Manag Res       Date:  2020-08-13       Impact factor: 3.989

2.  Ischemic Duodenal Ulceration after Transarterial Chemoembolization for Hepatocellular Carcinoma: A Case Report.

Authors:  Natascha Roehlen; Richard F Knoop; Katharina Laubner; Jochen Seufert; Henning Schwacha; Robert Thimme; Andreas Fischer
Journal:  Case Rep Gastroenterol       Date:  2018-06-28

3.  Metachronous double-hit by transarterial chemoembolisation (TACE) with fotemustine inducing dysplasia-like atypia in the gallbladder and stomach-A diagnostic pitfall.

Authors:  Ana I Varelas; Bence Kővári; Elisabeth Bruckner; Gregory Y Lauwers; Cord Langner
Journal:  Histopathology       Date:  2022-04-27       Impact factor: 7.778

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.